Literature DB >> 26740398

Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".

Eric J Nestler1.   

Abstract

UNLABELLED: In 1991 we demonstrated that chronic morphine exposure increased levels of adenylyl cyclase and protein kinase A (PKA) in several regions of the rat central nervous system as inferred from measures of enzyme activity in crude extracts (Terwilliger et al., 1991). These findings led us to hypothesize that a concerted upregulation of the cAMP pathway is a general mechanism of opiate tolerance and dependence. Moreover, in the same study we showed similar induction of adenylyl cyclase and PKA activity in nucleus accumbens (NAc) in response to chronic administration of cocaine, but not of several non-abused psychoactive drugs. Morphine and cocaine also induced equivalent changes in inhibitory G protein subunits in this brain region. We thus extended our hypothesis to suggest that, particularly within brain reward regions such as NAc, cAMP pathway upregulation represents a common mechanism of reward tolerance and dependence shared by several classes of drugs of abuse. Research since that time, by many laboratories, has provided substantial support for these hypotheses. Specifically, opiates in several CNS regions including NAc, and cocaine more selectively in NAc, induce expression of certain adenylyl cyclase isoforms and PKA subunits via the transcription factor, CREB, and these transcriptional adaptations serve a homeostatic function to oppose drug action. In certain brain regions, such as locus coeruleus, these adaptations mediate aspects of physical opiate dependence and withdrawal, whereas in NAc they mediate reward tolerance and dependence that drives increased drug self-administration. This work has had important implications for understanding the molecular basis of addiction. ORIGINAL ARTICLE ABSTRACT: "A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function". Previous studies have shown that chronic morphine increases levels of the G-protein subunits Giα and Goα, adenylate cyclase, cyclic AMP-dependent protein kinase, and certain phosphoproteins in the rat locus coeruleus, but not in several other brain regions studied, and that chronic morphine decreases levels of Giα and increases levels of adenylate cyclase in dorsal root ganglion/spinal cord (DRG-SC) co-cultures. These findings led us to survey the effects of chronic morphine on the G-protein/cyclic AMP system in a large number of brain regions to determine how widespread such regulation might be. We found that while most regions showed no regulation in response to chronic morphine, nucleus accumbens (NAc) and amygdala did show increases in adenylate cyclase and cyclic AMP-dependent protein kinase activity, and thalamus showed an increase in cyclic AMP-dependent protein kinase activity only. An increase in cyclic AMP-dependent protein kinase activity was also observed in DRG-SC co-cultures. Morphine regulation of G-proteins was variable, with decreased levels of Giα seen in the NAc, increased levels of Giα and Goα amygdala, and no change in thalamus or the other brain regions studied. Interestingly, chronic treatment of rats with cocaine, but not with several non-abused drugs, produced similar changes compared to morphine in G-proteins, adenylate cyclase, and cyclic AMP-dependent protein kinase in the NAc, but not in the other brain regions studied. These results indicate that regulation of the G-protein/cyclic AMP system represents a mechanism by which a number of opiate-sensitive neurons adapt to chronic morphine and thereby develop aspects of opiate tolerance and/or dependence. The findings that chronic morphine and cocaine produce similar adaptations in the NAc, a brain region important for the reinforcing actions of many types of abused substances, suggest further that common mechanisms may underlie psychological aspects of drug addiction mediated by this brain region. © 1991. This article is part of a Special Issue entitled SI:50th Anniversary Issue.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Adenylyl cyclase; CREB; Drugs of abuse; G alpha subunits; Opiates; Protein kinase A; Stimulants

Mesh:

Substances:

Year:  2015        PMID: 26740398      PMCID: PMC4927417          DOI: 10.1016/j.brainres.2015.12.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats.

Authors:  Erin B Larson; Danielle L Graham; Rose R Arzaga; Nicole Buzin; Joseph Webb; Thomas A Green; Caroline E Bass; Rachael L Neve; Ernest F Terwilliger; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Authors:  Michel Barrot; Jocelien D A Olivier; Linda I Perrotti; Ralph J DiLeone; Olivier Berton; Amelia J Eisch; Soren Impey; Daniel R Storm; Rachael L Neve; Jerry C Yin; Venetia Zachariou; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

Review 3.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

4.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

5.  Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

Authors:  R S Duman; J F Tallman; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin.

Authors:  M H Makman; B Dvorkin; S M Crain
Journal:  Brain Res       Date:  1988-04-05       Impact factor: 3.252

7.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

Review 8.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

9.  CREB modulates excitability of nucleus accumbens neurons.

Authors:  Yan Dong; Thomas Green; Daniel Saal; Helene Marie; Rachael Neve; Eric J Nestler; Robert C Malenka
Journal:  Nat Neurosci       Date:  2006-03-05       Impact factor: 24.884

10.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens.

Authors:  M J Miserendino; E J Nestler
Journal:  Brain Res       Date:  1995-03-20       Impact factor: 3.252

View more
  17 in total

1.  Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.

Authors:  Sunny Zhihong Jiang; Sean Sweat; Sam P Dahlke; Kathleen Loane; Gunner Drossel; Wenqin Xu; Hugo A Tejeda; Charles R Gerfen; Lee E Eiden
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

2.  Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities.

Authors:  Christopher M Olsen; Qing-Song Liu
Journal:  Front Biol (Beijing)       Date:  2016-10-17

3.  Differential expression of long-term potentiation among identified inhibitory inputs to dopamine neurons.

Authors:  DeNard V Simmons; Alyssa K Petko; Carlos A Paladini
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

4.  Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits.

Authors:  Brian S Muntean; Stefano Zucca; Courtney M MacMullen; Maria T Dao; Caitlin Johnston; Hideki Iwamoto; Randy D Blakely; Ronald L Davis; Kirill A Martemyanov
Journal:  Cell Rep       Date:  2018-01-02       Impact factor: 9.423

5.  CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured.

Authors:  Christopher S Walker; Ann C Raddant; Michael J Woolley; Andrew F Russo; Debbie L Hay
Journal:  Cephalalgia       Date:  2017-02-06       Impact factor: 6.292

6.  Response of the Tail of the Ventral Tegmental Area to Aversive Stimuli.

Authors:  María-José Sánchez-Catalán; Fanny Faivre; Ipek Yalcin; Marc-Antoine Muller; Dominique Massotte; Monique Majchrzak; Michel Barrot
Journal:  Neuropsychopharmacology       Date:  2016-07-29       Impact factor: 7.853

7.  Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats.

Authors:  Ryan S Poland; Yun Hahn; Pamela E Knapp; Patrick M Beardsley; M Scott Bowers
Journal:  Neuropharmacology       Date:  2016-06-22       Impact factor: 5.250

8.  Cocaine Self-administration Alters Transcriptome-wide Responses in the Brain's Reward Circuitry.

Authors:  Deena M Walker; Hannah M Cates; Yong-Hwee E Loh; Immanuel Purushothaman; Aarthi Ramakrishnan; Kelly M Cahill; Casey K Lardner; Arthur Godino; Hope G Kronman; Jacqui Rabkin; Zachary S Lorsch; Philipp Mews; Marie A Doyle; Jian Feng; Benoit Labonté; Ja Wook Koo; Rosemary C Bagot; Ryan W Logan; Marianne L Seney; Erin S Calipari; Li Shen; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2018-04-25       Impact factor: 13.382

9.  Overexpression of Protein Kinase Inhibitor Alpha Reverses Rat Low Voluntary Running Behavior.

Authors:  Kolter B Grigsby; Gregory N Ruegsegger; Thomas E Childs; Frank W Booth
Journal:  Mol Neurobiol       Date:  2018-06-21       Impact factor: 5.590

Review 10.  Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.

Authors:  Abhishekh H Ashok; Yuya Mizuno; Nora D Volkow; Oliver D Howes
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.